OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global Epidemiology of Drug-Induced Liver Injury (DILI)
Einar S. Björnsson
Current Hepatology Reports (2019) Vol. 18, Iss. 3, pp. 274-279
Closed Access | Times Cited: 15

Showing 15 citing articles:

The Epidemiology of Newly Recognized Causes of Drug-Induced Liver Injury: An Update
Einar S. Björnsson
Pharmaceuticals (2024) Vol. 17, Iss. 4, pp. 520-520
Open Access | Times Cited: 8

Drug-induced Fatty Liver Disease: Pathogenesis and Treatment
Tea Omanović Kolarić, Vjera Ninčević, Lucija Kuna, et al.
Journal of Clinical and Translational Hepatology (2021) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 32

The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment
Giulia Callegaro, Steven J. Kunnen, Panuwat Trairatphisan, et al.
Archives of Toxicology (2021) Vol. 95, Iss. 12, pp. 3745-3775
Open Access | Times Cited: 32

Enhancing DILI Toxicity Prediction through Integrated Graph Attention (GATNN) and Dense Neural Networks (DNN).
Agung Surya Wibowo, Kil To Chong, Hilal Tayara
Toxicology (2025), pp. 154108-154108
Closed Access

Combination Treatment of Omega-3 Fatty Acids and Vitamin C Exhibited Promising Therapeutic Effect against Oxidative Impairment of the Liver in Methotrexate-Intoxicated Mice
Mohammed Alorabi, Doha Saad Mohammed, Gomaa Mostafa‐Hedeab, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 15

Incidence of Idiosyncratic Drug-Induced Liver Injury Caused by Prescription Drugs
Vincent Chen, Don C. Rockey, Einar S. Björnsson, et al.
Drug Safety (2024)
Closed Access | Times Cited: 2

Prospects of Probiotic Adjuvant Drugs in Clinical Treatment
Zhongyue Ren, Hong Yan, Yalan Huo, et al.
Nutrients (2022) Vol. 14, Iss. 22, pp. 4723-4723
Open Access | Times Cited: 11

Hepatic impacts of gold nanoparticles with different surface coatings as revealed by assessing the hepatic drug-metabolizing enzyme and lipid homeostasis in mice
Shuang Zhou, Li Xue, Meilin Zhu, et al.
NanoImpact (2020) Vol. 20, pp. 100259-100259
Closed Access | Times Cited: 15

Drug-Induced Liver Injury
Narendra Singh Choudhary, Neeraj Saraf, Vinod Kumar, et al.
Journal of Clinical and Preventive Cardiology (2022) Vol. 11, Iss. 3, pp. 79-82
Open Access | Times Cited: 6

Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury
Maud Maillard, Cécile Arellano, Christelle Vachoux, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 852-852
Open Access | Times Cited: 3

Activation of HSPA5 contributes to pazopanib-induced hepatotoxicity through l-ornithine metabolism pathway and endoplasmic reticulum stress
Jian Chen, Tieming Zhu, Ya-Ping Deng, et al.
Journal of Pharmacy and Pharmacology (2024)
Closed Access

Nanobody-based pannexin1 channel inhibitors reduce inflammation in acute liver injury
Raf Van Campenhout, Timo W. M. De Groof, Prashant Kadam, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 1

The human hepatocyte TXG-MAPr: WGCNA transcriptomic modules to support mechanism-based risk assessment
Giulia Callegaro, Steven J. Kunnen, Panuwat Trairatphisan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1

Page 1

Scroll to top